Logo image of EXO.AS

EXOR NV (EXO.AS) Stock Fundamental Analysis

Europe - AMS:EXO - NL0012059018 - Common Stock

76.15 EUR
+0.7 (+0.93%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, EXO scores 4 out of 10 in our fundamental rating. EXO was compared to 50 industry peers in the Financial Services industry. EXO has a great financial health rating, but its profitability evaluates not so good. EXO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EXO had negative earnings in the past year.
EXO had a positive operating cash flow in the past year.
Of the past 5 years EXO 4 years were profitable.
EXO had a positive operating cash flow in each of the past 5 years.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

The Return On Assets of EXO (-1.62%) is worse than 74.00% of its industry peers.
Looking at the Return On Equity, with a value of -1.78%, EXO is doing worse than 68.00% of the companies in the same industry.
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

EXO's Profit Margin has improved in the last couple of years.
EXO's Operating Margin has improved in the last couple of years.
With a Gross Margin value of -5096.69%, EXO is not doing good in the industry: 64.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of EXO has grown nicely.
EXO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -5096.69%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

8

2. Health

2.1 Basic Checks

EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EXO has less shares outstanding
Compared to 5 years ago, EXO has less shares outstanding
EXO has a better debt/assets ratio than last year.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

EXO has an Altman-Z score of 3.88. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
EXO has a better Altman-Z score (3.88) than 76.00% of its industry peers.
EXO has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
The Debt to FCF ratio of EXO (1.25) is better than 80.00% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.08, EXO is doing good in the industry, outperforming 74.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Altman-Z 3.88
ROIC/WACCN/A
WACC4.76%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 2.21 indicates that EXO has no problem at all paying its short term obligations.
EXO's Current ratio of 2.21 is fine compared to the rest of the industry. EXO outperforms 74.00% of its industry peers.
EXO has a Quick Ratio of 2.21. This indicates that EXO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.21, EXO is in the better half of the industry, outperforming 78.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

0

3. Growth

3.1 Past

The earnings per share for EXO have decreased strongly by -104.11% in the last year.
EXO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.47% yearly.
Looking at the last year, EXO shows a very negative growth in Revenue. The Revenue has decreased by -100.78% in the last year.
EXO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.03% yearly.
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%

3.2 Future

The Earnings Per Share is expected to decrease by -51.47% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-121.49%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 23.38, which indicates a rather expensive current valuation of EXO.
EXO's Price/Forward Earnings is on the same level as the industry average.
EXO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.18.
Industry RankSector Rank
PE N/A
Fwd PE 23.38
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

84.00% of the companies in the same industry are more expensive than EXO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.63
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

EXO's earnings are expected to decrease with -51.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.64%, EXO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.62, EXO has a dividend in line with its industry peers.
With a Dividend Yield of 0.64, EXO pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

EXO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
EXO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-14.35%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

More info and screens

EXOR NV

AMS:EXO (10/20/2025, 7:00:00 PM)

76.15

+0.7 (+0.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-17 2025-09-17
Earnings (Next)03-24 2026-03-24
Inst Owners29.18%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap15.82B
Analysts85
Price Target119.72 (57.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP-14.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.57%
PT rev (3m)0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-208.7%
EPS NY rev (3m)-194.36%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.38
P/S N/A
P/FCF 5.63
P/OCF 5.63
P/B 0.44
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-3.12
EYN/A
EPS(NY)3.26
Fwd EY4.28%
FCF(TTM)13.53
FCFY17.77%
OCF(TTM)13.53
OCFY17.77%
SpS-1.45
BVpS174.97
TBVpS174.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -5096.69%
FCFM -931.13%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z 3.88
F-Score5
WACC4.76%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
EPS Next Y-121.49%
EPS Next 2Y-69.14%
EPS Next 3Y-51.47%
EPS Next 5YN/A
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%
Revenue Next Year6.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-102.73%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.71%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-52.81%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%